calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate
Drug data last refreshed 11h ago · AI intelligence enriched 4d ago
Methotrexate Sodium is an irrigation solution containing methotrexate in a balanced electrolyte formulation (calcium chloride, dextrose, glutathione disulfide, magnesium chloride, potassium chloride, sodium bicarbonate, sodium chloride, sodium phosphate). The specific clinical indication is not documented in available data, but the irrigation route suggests use in surgical or topical applications. This formulation is designed to maintain cellular viability during procedures requiring extended irrigation.
With LOE approaching and 30% competitive pressure, this product is in a defensive positioning phase with likely downsizing of commercial support.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
This product currently shows zero linked job openings, reflecting its mature lifecycle stage and approaching loss of exclusivity. Career opportunities on this brand are limited and likely focused on legacy product support and transition planning rather than growth initiatives.
Worked on METHOTREXATE SODIUM at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo